These models confirmed the significance of clinical factors such as a family history of IBD, age, and anti-TNF therapy, alongside the genotypes rs9936833, rs3132680, rs3823417, and rs4410871, in predicting EIMs. This evidence concerns the gene TNF and inflammatory bowel disease.